Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I5ZM
|
||||
Former ID |
DIB009235
|
||||
Drug Name |
Remogli ozin-etabonate
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 2 | [550338] | ||
Company |
Bhv pharma
|
||||
Target and Pathway | |||||
Target(s) | Sodium/glucose cotransporter 2 | Target Info | Modulator | [532334] | |
WikiPathways | NRF2 pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.